{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:04:03Z","timestamp":1792479843354,"version":"4.5.0"},"reference-count":112,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1053\/j.semdp.2021.06.007","type":"journal-article","created":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T13:20:48Z","timestamp":1623763248000},"page":"120-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Mediastinal neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: Pathology review and diagnostic approach"],"prefix":"10.1053","volume":"39","author":[{"given":"Joon Hyuk","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Y.","family":"Ro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semdp.2021.06.007_bib0001","series-title":"WHO Classification of Tumours of Endocrine Organs","first-page":"196","article-title":"Neuroblastic tumours of the adrenal gland","author":"Shimada","year":"2017"},{"key":"10.1053\/j.semdp.2021.06.007_bib0002","series-title":"Enzinger & Weiss's soft Tissue tumors, 7th ed.","first-page":"991","article-title":"Peripheral neuroblastic tumors","author":"Shimada","year":"2020"},{"key":"10.1053\/j.semdp.2021.06.007_bib0003","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1470-2045(04)01385-3","article-title":"Uncommon primary mediastinal tumours","volume":"5","author":"Macchiarini","year":"2004","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.semdp.2021.06.007_bib0004","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0003-4975(10)65676-7","article-title":"Neurogenic tumors of the mediastinum","volume":"17","author":"Gale","year":"1974","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.semdp.2021.06.007_bib0005","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0046-8177(96)90094-5","article-title":"Ganglioneuroblastoma of the thymus: an adult case with the syndrome of inappropriate secretion of antidiuretic hormone","volume":"27","author":"Asada","year":"1996","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2021.06.007_bib0006","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0344-0338(97)80034-9","article-title":"Adult ganglioneuroblastoma of the anterior mediastinum","volume":"193","author":"Nagashima","year":"1997","journal-title":"Pathol Res Pract"},{"key":"10.1053\/j.semdp.2021.06.007_bib0007","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/ajcp\/108.5.537","article-title":"Thymic neuroblastoma in adults: report of three cases with special emphasis on its association with the syndrome of inappropriate secretion of antidiuretic hormone","volume":"108","author":"Argani","year":"1997","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2021.06.007_bib0008","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/1097-0142(20010515)91:10<1905::AID-CNCR1213>3.0.CO;2-4","article-title":"Metabolic activity and clinical features of primary ganglioneuromas","volume":"91","author":"Geoerger","year":"2001","journal-title":"Canc"},{"key":"10.1053\/j.semdp.2021.06.007_bib0009","doi-asserted-by":"crossref","first-page":"214","DOI":"10.5858\/arpa.2019-0570-OA","article-title":"Multinational retrospective central pathology review of neuroblastoma: lessons learned to establish a regional pathology referral center in resource-limited settings","volume":"145","author":"Santiago","year":"2021","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.semdp.2021.06.007_bib0010","doi-asserted-by":"crossref","first-page":"6459","DOI":"10.1200\/JCO.2005.05.571","article-title":"Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the children's oncology group","volume":"23","author":"London","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2021.06.007_bib0011","doi-asserted-by":"crossref","first-page":"16078","DOI":"10.1038\/nrdp.2016.78","article-title":"Neuroblastoma","volume":"2","author":"Matthay","year":"2016","journal-title":"Nat Rev Dis Primer"},{"key":"10.1053\/j.semdp.2021.06.007_bib0012","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/1097-0142(19810115)47:2<373::AID-CNCR2820470227>3.0.CO;2-O","article-title":"Ganglioneuroblastoma of the posterior mediastinum: a clinicopathologic review of 80 cases","volume":"47","author":"Adam","year":"1981","journal-title":"Canc"},{"key":"10.1053\/j.semdp.2021.06.007_bib0013","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1378\/chest.44.1.79","article-title":"Neurogenous tumors of the mediastinum: a clinicopathologic study based on 50 cases","volume":"44","author":"Pachter","year":"1963","journal-title":"Dis Chest"},{"key":"10.1053\/j.semdp.2021.06.007_bib0014","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00043426-199905000-00005","article-title":"Metastatic sites in stage iv and ivs neuroblastoma correlate with age, tumor biology, and survival","volume":"21","author":"DuBois","year":"1999","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1053\/j.semdp.2021.06.007_bib0015","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/pbc.20888","article-title":"Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients","volume":"48","author":"Strenger","year":"2007","journal-title":"Pediatr Blood Canc"},{"key":"10.1053\/j.semdp.2021.06.007_bib0016","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ajo.2006.05.047","article-title":"Pediatric horner syndrome: etiologies and roles of imaging and urine studies to detect neuroblastoma and other responsible mass lesions","volume":"142","author":"Mahoney","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1053\/j.semdp.2021.06.007_bib0017","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S2352-4642(17)30129-3","article-title":"Enigmatic entities: opsoclonus myoclonus ataxia syndrome linked to neuroblastoma","volume":"2","author":"Kushner","year":"2018","journal-title":"Lancet Child Adolesc Heal\\"},{"key":"10.1053\/j.semdp.2021.06.007_bib0018","doi-asserted-by":"crossref","first-page":"7929","DOI":"10.3748\/wjg.v21.i25.7929","article-title":"Refractory diarrhea: a paraneoplastic syndrome of neuroblastoma","volume":"21","author":"Han","year":"2015","journal-title":"Worl J Gastroenterol"},{"key":"10.1053\/j.semdp.2021.06.007_bib0019","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/pbc.25723","article-title":"Oncologic phenotype of peripheral neuroblastic tumors associated with phox2b non-polyalanine repeat expansion mutations","volume":"63","author":"Heide","year":"2016","journal-title":"Pediatr Blood Canc"},{"key":"10.1053\/j.semdp.2021.06.007_bib0020","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/10408363.2012.683483","article-title":"Neuroblastoma: the impact of biology and cooperation leading to personalized treatments","volume":"49","author":"Owens","year":"2012","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1053\/j.semdp.2021.06.007_bib0021","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/sj.bjc.6605621","article-title":"Criteria for evaluation of disease extent by 123i-metaiodobenzylguanidine scans in neuroblastoma: a report for the international neuroblastoma risk group (inrg) task force","volume":"102","author":"Matthay","year":"2010","journal-title":"Br J Canc"},{"key":"10.1053\/j.semdp.2021.06.007_bib0022","article-title":"Evaluation of norepinephrine transporter expression and metaiodobenzylguanidine avidity in neuroblastoma: a report from the children's oncology group","volume":"2012","author":"Dubois","year":"2012","journal-title":"Int J Mol Imag"},{"key":"10.1053\/j.semdp.2021.06.007_bib0023","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00259-011-1938-2","article-title":"Comparison of 18f-dopa pet\/ct and 123i-mibg scintigraphy in stage 3 and 4 neuroblastoma: a pilot study","volume":"39","author":"Piccardo","year":"2012","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1053\/j.semdp.2021.06.007_bib0024","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2967\/jnumed.108.060467","article-title":"123I-MIBG scintigraphy and 18f-fdg pet in neuroblastoma","volume":"50","author":"Sharp","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semdp.2021.06.007_bib0025","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1016\/S1470-2045(13)70236-5","article-title":"Neonatal cancer","volume":"14","author":"Orbach","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.semdp.2021.06.007_bib0026","series-title":"Neuroblastoma. Clinical and Surgical management. 1st ed.","first-page":"3","article-title":"Epidemiology","author":"Clavel","year":"2020"},{"key":"10.1053\/j.semdp.2021.06.007_bib0027","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nature07261","article-title":"Identification of alk as a major familial neuroblastoma predisposition gene","volume":"455","author":"Moss\u00e9","year":"2008","journal-title":"Nat"},{"key":"10.1053\/j.semdp.2021.06.007_bib0028","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/sj.onc.1210659","article-title":"Prevalence and functional consequence of phox2b mutations in neuroblastoma","volume":"27","author":"Raabe","year":"2008","journal-title":"Oncogene"},{"key":"10.1053\/j.semdp.2021.06.007_bib0029","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1002\/ijc.32161","article-title":"Parental smoking, maternal alcohol consumption during pregnancy and the risk of neuroblastoma in children. a pooled analysis of the escale and estelle french studies","volume":"145","author":"Petit","year":"2019","journal-title":"Int J Canc"},{"key":"10.1053\/j.semdp.2021.06.007_bib0030","first-page":"1125","article-title":"Maternal use of household pesticides during pregnancy and risk of neuroblastoma in offspring. a pooled analysis of the estelle and escale french studies (sfce)","volume":"28","author":"Rios","year":"2017","journal-title":"Canc Cause Contr"},{"key":"10.1053\/j.semdp.2021.06.007_bib0031","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1002\/ijc.30239","article-title":"Risk of neuroblastoma, birth-related characteristics, congenital malformations and perinatal exposures: a pooled analysis of the escale and estelle french studies (sfce)","volume":"139","author":"Rios","year":"2016","journal-title":"Int J Canc"},{"key":"10.1053\/j.semdp.2021.06.007_bib0032","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/aje\/kwh108","article-title":"Maternal medication use and neuroblastoma in offspring","volume":"159","author":"Cook","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1053\/j.semdp.2021.06.007_bib0033","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0009-9236(03)00200-5","article-title":"Folic acid food fortification is associated with a decline in neuroblastoma","volume":"74","author":"French","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1053\/j.semdp.2021.06.007_bib0034","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/aje\/kwh111","article-title":"Day care, childhood infections, and risk of neuroblastoma","volume":"159","author":"Menegaux","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1053\/j.semdp.2021.06.007_bib0035","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.canep.2014.09.007","article-title":"Risk of neuroblastoma, maternal characteristics and perinatal exposures: the setil study","volume":"38","author":"Parodi","year":"2014","journal-title":"Canc Epidemiol"},{"key":"10.1053\/j.semdp.2021.06.007_bib0036","first-page":"527","article-title":"Disseminated metastasis of neuroblastomatous component in immature mediastinal teratoma: a case report","volume":"20","author":"Ohtsuka","year":"2000","journal-title":"Anticanc Res"},{"key":"10.1053\/j.semdp.2021.06.007_bib0037","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S1726-4901(09)70306-5","article-title":"Malignant ganglioneuroma arising from mediastinal mixed germ cell tumor","volume":"70","author":"Chen","year":"2007","journal-title":"J Chin Med Assoc"},{"key":"10.1053\/j.semdp.2021.06.007_bib0038","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1365-2559.2008.03078.x","article-title":"Differentiating neuroblastoma arising in mediastinal germ cell tumour","volume":"53","author":"Pelosi","year":"2008","journal-title":"Histopathol"},{"key":"10.1053\/j.semdp.2021.06.007_bib0039","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00428-007-0544-y","article-title":"Thymoma with ganglioneuroblastomatous component: case report","volume":"452","author":"Kashiwabara","year":"2008","journal-title":"Virchows Arch"},{"key":"10.1053\/j.semdp.2021.06.007_bib0040","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/cncr.29706","article-title":"Advances in the translational genomics of neuroblastoma: from improving risk stratification and revealing novel biology to identifying actionable genomic alterations","volume":"122","author":"Bosse","year":"2016","journal-title":"Canc"},{"key":"10.1053\/j.semdp.2021.06.007_bib0041","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1093\/jnci\/djz027","article-title":"Differences in genomic profiles and outcomes between thoracic and adrenal neuroblastoma","volume":"111","author":"Oldridge","year":"2019","journal-title":"J Natl Canc Inst"},{"key":"10.1053\/j.semdp.2021.06.007_bib0042","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/sj.bjc.6605014","article-title":"International consensus for neuroblastoma molecular diagnostics: report from the international neuroblastoma risk group (inrg) biology committee","volume":"100","author":"Ambros","year":"2009","journal-title":"Br J Canc"},{"key":"10.1053\/j.semdp.2021.06.007_bib0043","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/bjc.2015.188","article-title":"Augmented expression of myc and\/or mycn protein defines highly aggressive myc-driven neuroblastoma: a children's oncology group study","volume":"113","author":"Wang","year":"2015","journal-title":"Br J Canc"},{"key":"10.1053\/j.semdp.2021.06.007_bib0044","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.canlet.2015.06.015","article-title":"MYCN- driven regulatory mechanisms controlling lin28b in neuroblastoma","volume":"366","author":"Beckers","year":"2015","journal-title":"Canc Lett"},{"key":"10.1053\/j.semdp.2021.06.007_bib0045","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1002\/1097-0142(20011115)92:10<2699::AID-CNCR1624>3.0.CO;2-A","article-title":"Histopathology (international neuroblastoma pathology classification) and mycn status in patients with peripheral neuroblastic tumors: a report from the children's cancer group","volume":"92","author":"Goto","year":"2001","journal-title":"Canc"},{"key":"10.1053\/j.semdp.2021.06.007_bib0046","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1002\/cncr.28251","article-title":"Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and myc\/mycn protein expression: a report from the children\u2019s oncology group","volume":"119","author":"Wang","year":"2013","journal-title":"Canc"},{"key":"10.1053\/j.semdp.2021.06.007_bib0047","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/nature07399","article-title":"Oncogenic mutations of alk kinase in neuroblastoma","volume":"455","author":"Chen","year":"2008","journal-title":"Nat"},{"key":"10.1053\/j.semdp.2021.06.007_bib0048","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature07398","article-title":"Somatic and germline activating mutations of the alk kinase receptor in neuroblastoma","volume":"455","author":"Janoueix-Lerosey","year":"2008","journal-title":"Nat"},{"key":"10.1053\/j.semdp.2021.06.007_bib0049","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/ng.2529","article-title":"The genetic landscape of high-risk neuroblastoma","volume":"45","author":"Pugh","year":"2013","journal-title":"Nat Genet"},{"key":"10.1053\/j.semdp.2021.06.007_bib0050","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrc3526","article-title":"Neuroblastoma: developmental biology, cancer genomics and immunotherapy","volume":"13","author":"Cheung","year":"2013","journal-title":"Nat Rev Canc"},{"key":"10.1053\/j.semdp.2021.06.007_bib0051","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/jama.2012.228","article-title":"Association of age at diagnosis and genetic mutations in patients with neuroblastoma","volume":"307","author":"Cheung","year":"2012","journal-title":"JAMA"},{"key":"10.1053\/j.semdp.2021.06.007_bib0052","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/15384101.2015.1125243","article-title":"Telomere maintenance is pivotal for high-risk neuroblastoma","volume":"15","author":"Hertwig","year":"2016","journal-title":"Cell Cyc"},{"key":"10.1053\/j.semdp.2021.06.007_bib0053","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MPH.0000000000000840","article-title":"TERT-mediated and atrx-mediated telomere maintenance and neuroblastoma","volume":"40","author":"Duan","year":"2018","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1053\/j.semdp.2021.06.007_bib0054","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1038\/ng.3438","article-title":"TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors","volume":"47","author":"Valentijn","year":"2015","journal-title":"Nat Genet"},{"key":"10.1053\/j.semdp.2021.06.007_bib0055","doi-asserted-by":"crossref","first-page":"6466","DOI":"10.1200\/JCO.2005.05.582","article-title":"Hyperdiploidy plus nonamplified mycn confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a pediatric oncology group study","volume":"23","author":"George","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2021.06.007_bib0056","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1056\/NEJM198407263110405","article-title":"Cellular dna content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma","volume":"311","author":"Look","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semdp.2021.06.007_bib0057","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1073\/pnas.0910684107","article-title":"High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset","volume":"107","author":"Car\u00e9n","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.semdp.2021.06.007_bib0058","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1056\/NEJMoa052399","article-title":"Chromosome 1p and 11q deletions and outcome in neuroblastoma","volume":"353","author":"Attiyeh","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semdp.2021.06.007_bib0059","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMra0804577","article-title":"Recent advances in neuroblastoma","volume":"362","author":"Maris","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semdp.2021.06.007_bib0060","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1056\/NEJM199906243402504","article-title":"Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma","volume":"340","author":"Bown","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semdp.2021.06.007_bib0061","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/bjc.2012.375","article-title":"Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project","volume":"107","author":"Schleiermacher","year":"2012","journal-title":"Br J Canc"},{"key":"10.1053\/j.semdp.2021.06.007_bib0062","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1023\/A:1005729329526","article-title":"Expression of trka, trkb and trkc in human neuroblastomas","volume":"31","author":"Brodeur","year":"1997","journal-title":"J Neurooncol"},{"key":"10.1053\/j.semdp.2021.06.007_bib0063","first-page":"759","article-title":"Expression and function of trk-b and bdnf in human neuroblastomas","volume":"14","author":"Nakagawara","year":"1994","journal-title":"Mol Cell Biol"},{"key":"10.1053\/j.semdp.2021.06.007_bib0064","doi-asserted-by":"crossref","first-page":"E6603","DOI":"10.1073\/pnas.1706011114","article-title":"Rho-associated kinase is a therapeutic target in neuroblastoma","volume":"114","author":"Dyberg","year":"2017","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1053\/j.semdp.2021.06.007_bib0065","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/ng.2493","article-title":"Integrated genomic analyses identify arid1a and arid1b alterations in the childhood cancer neuroblastoma","volume":"45","author":"Sausen","year":"2013","journal-title":"Nat Genet"},{"key":"10.1053\/j.semdp.2021.06.007_bib0066","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1158\/0008-5472.CAN-11-3703","article-title":"Common variation at bard1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity","volume":"72","author":"Bosse","year":"2012","journal-title":"Canc Res"},{"key":"10.1053\/j.semdp.2021.06.007_bib0067","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/carcin\/bgs380","article-title":"Replication of gwas-identified neuroblastoma risk loci strengthens the role of bard1 and affirms the cumulative effect of genetic variations on disease susceptibility","volume":"34","author":"Capasso","year":"2013","journal-title":"Carcinogene"},{"key":"10.1053\/j.semdp.2021.06.007_bib0068","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/ng.2387","article-title":"Common variation at 6q16 within hace1 and lin28b influences susceptibility to neuroblastoma","volume":"44","author":"Diskin","year":"2012","journal-title":"Nat Genet"},{"key":"10.1053\/j.semdp.2021.06.007_bib0069","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002026","article-title":"Phenotype restricted genome-wide association study using a gene-centric approach identifies three low-risk neuroblastoma susceptibility loci","volume":"7","author":"Nguyen le","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1053\/j.semdp.2021.06.007_bib0070","doi-asserted-by":"crossref","first-page":"5098","DOI":"10.3390\/ijms21145098","article-title":"Identification of rna-binding proteins as targetable putative oncogenes in neuroblastoma","volume":"21","author":"Bell","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1053\/j.semdp.2021.06.007_bib0071","doi-asserted-by":"crossref","first-page":"874","DOI":"10.5858\/2005-129-874-PFTEOS","article-title":"Cancer committee, college of american pathologists. protocol for the examination of specimens from patients with neuroblastoma and related neuroblastic tumors","volume":"129","author":"Qualman","year":"2005","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.semdp.2021.06.007_bib0072","series-title":"Protocol For the Examination of Resection Specimens from Patients With Neuroblastoma","author":"s","year":"2019"},{"key":"10.1053\/j.semdp.2021.06.007_bib0073","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/(SICI)1097-0142(19990715)86:2<349::AID-CNCR20>3.0.CO;2-Y","article-title":"Terminology and morphologic criteria of neuroblastic tumors: recommendations by the international neuroblastoma pathology committee","volume":"86","author":"Shimada","year":"1999","journal-title":"Canc"},{"key":"10.1053\/j.semdp.2021.06.007_bib0074","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.0.CO;2-7","article-title":"The international neuroblastoma pathology classification (the shimada system)","volume":"86","author":"Shimada","year":"1999","journal-title":"Canc"},{"key":"10.1053\/j.semdp.2021.06.007_bib0075","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1002\/cncr.11773","article-title":"Revision of the international neuroblastoma pathology classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular","volume":"98","author":"Peuchmaur","year":"2003","journal-title":"Canc"},{"key":"10.1053\/j.semdp.2021.06.007_bib0076","series-title":"WHO Classification of Tumours of Lung, Pleura, Thymus and Heart. 4th ed.","first-page":"294","article-title":"Ganglioneuroma, ganglioneuroblastoma, and neuroblastoma","author":"Marx","year":"2015"},{"key":"10.1053\/j.semdp.2021.06.007_bib0077","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/cncr.20717","article-title":"Enlarged and prominent nucleoli may be indicative of mycn amplification: a study of neuroblastoma (schwannian stroma-poor), undifferentiated\/poorly differentiated subtype with high mitosis-karyorrhexis index","volume":"103","author":"Kobayashi","year":"2005","journal-title":"Canc"},{"key":"10.1053\/j.semdp.2021.06.007_bib0078","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3389\/fonc.2014.00202","article-title":"Ultra-high density snparray in neuroblastoma molecular diagnostics","volume":"4","author":"Ambros","year":"2014","journal-title":"Front Oncol"},{"key":"10.1053\/j.semdp.2021.06.007_bib0079","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/cncr.20005","article-title":"Large cell neuroblastoma: a distinct phenotype of neuroblastoma with aggressive clinical behavior","volume":"100","author":"Torn\u00f3czky","year":"2004","journal-title":"Canc"},{"key":"10.1053\/j.semdp.2021.06.007_bib0080","first-page":"621","article-title":"Pleomorphic (anaplastic) neuroblastoma","volume":"112","author":"Cozzutto","year":"1988","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.semdp.2021.06.007_bib0081","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2350\/14-06-1505-OA.1","article-title":"Age- dependent prognostic effect by mitosis-karyorrhexis index in neuroblastoma: a report from the children's oncology group","volume":"17","author":"Teshiba","year":"2014","journal-title":"Pediatr Dev Pathol"},{"key":"10.1053\/j.semdp.2021.06.007_bib0082","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1097\/PAS.0000000000000478","article-title":"MIB-1 index as a surrogate for mitosis-karyorrhexis index in neuroblastoma","volume":"39","author":"Atikankul","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2021.06.007_bib0083","series-title":"Diagnostic Histopathology of Tumors, 5th ed.","first-page":"2201","article-title":"Tumors of the autonomic nervous system, including paraganglia","author":"Lack","year":"2021"},{"key":"10.1053\/j.semdp.2021.06.007_bib0084","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/PAT.0000000000000317","article-title":"Malignant peripheral nerve sheath tumour arising de novo from ganglioneuroma","volume":"47","author":"Mow","year":"2015","journal-title":"Pathol"},{"key":"10.1053\/j.semdp.2021.06.007_bib0085","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12022-017-9494-3","article-title":"Composite pheochromocytoma\/paraganglioma-ganglioneuroma: a clinicopathologic study of eight cases with analysis of succinate dehydrogenase","volume":"28","author":"Gupta","year":"2017","journal-title":"Endocr Pathol"},{"key":"10.1053\/j.semdp.2021.06.007_bib0086","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00000478-199803000-00007","article-title":"Monoclonal antibody nb84 in the differential diagnosis of neuroblastoma and other small round cell tumors","volume":"22","author":"Miettinen","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2021.06.007_bib0087","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/PAS.0b013e31825a6895","article-title":"PHOX2B immunolabeling: a novel tool for the diagnosis of undifferentiated neuroblastomas among childhood small round blue-cell tumors","volume":"36","author":"Bielle","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2021.06.007_bib0088","doi-asserted-by":"crossref","first-page":"543","DOI":"10.5858\/arpa.2014-0255-OA","article-title":"Diagnostic utility of phox2b in primary and treated neuroblastoma and in neuroblastoma metastatic to the bone marrow","volume":"139","author":"Hata","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.semdp.2021.06.007_bib0089","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2350\/15-11-1736-LET.1","article-title":"Importance of phox2b immunohistochemical stain for detecting metastatic neuroblastoma cells in bone marrow specimens","volume":"19","author":"Warren","year":"2016","journal-title":"Pediatr Dev Pathol"},{"key":"10.1053\/j.semdp.2021.06.007_bib0090","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/his.13412","article-title":"Utility of phox2b immunohistochemical stain in neural crest tumours and non-neural crest tumours in paediatric patients","volume":"72","author":"Warren","year":"2018","journal-title":"Histopathol"},{"key":"10.1053\/j.semdp.2021.06.007_bib0091","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.humpath.2018.11.004","article-title":"HuC\/D expression in small round cell tumors and neuroendocrine tumors: a useful tool for distinguishing neuroblastoma from childhood small round cell tumors","volume":"85","author":"Takemoto","year":"2019","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2021.06.007_bib0092","first-page":"940","article-title":"GATA3 is a reliable marker for neuroblastoma in limited samples, including fna cell blocks, core biopsies, and touch imprints","volume":"125","author":"Wiles","year":"2017","journal-title":"Canc Cytopathol"},{"key":"10.1053\/j.semdp.2021.06.007_bib0093","series-title":"Neuroblastoma. Clinical and Surgical management. 1st ed.","first-page":"3","article-title":"Neuroblastoma pathology","author":"Shimada","year":"2020"},{"key":"10.1053\/j.semdp.2021.06.007_bib0094","series-title":"Enzinger & Weiss's soft Tissue tumors, 7th ed.","first-page":"121","article-title":"Peripheral neuroblastic tumors","author":"Goldblum","year":"2020"},{"issue":"1","key":"10.1053\/j.semdp.2021.06.007_bib0095","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1038\/modpathol.2013.177","article-title":"Novel uses of immunohistochemistry in the diagnosis and classification of soft tissue tumors","author":"Hornick","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2021.06.007_bib0096","doi-asserted-by":"crossref","first-page":"326","DOI":"10.5858\/2008-132-326-UTTIBI","article-title":"Undifferentiated tumor: true identity by immunohistochemistry","volume":"132","author":"Bahrami","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.semdp.2021.06.007_bib0097","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.anndiagpath.2017.11.011","article-title":"Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, \"undifferentiated small round cell tumors\". A clinicopathologic, immunophenotypic and molecular analysis","volume":"34","author":"Machado","year":"2018","journal-title":"Ann Diagn Pathol"},{"key":"10.1053\/j.semdp.2021.06.007_bib0098","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.path.2015.06.001","article-title":"Advances in the molecular analysis of soft tissue tumors and clinical implications","volume":"8","author":"Marino-Enriquez","year":"2015","journal-title":"Surg Pathol Clin"},{"key":"10.1053\/j.semdp.2021.06.007_bib0099","series-title":"Biopsy Interpretation of Soft Tissue tumors. 2nd ed.","first-page":"315","article-title":"Small round cell tumors","author":"Fisher","year":"2016"},{"key":"10.1053\/j.semdp.2021.06.007_bib0100","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1038\/s41379-019-0301-1","article-title":"Clinical, pathological, and genomic features of ewsr1-patz1 fusion sarcoma","volume":"32","author":"Bridge","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2021.06.007_bib0101","series-title":"CIC-rearranged sarcoma. In: The WHO Classification of Tumours Editorial board. WHO Classification of tumours. Soft tissue and Bone tumours, 5th ed.","first-page":"330","author":"Antonescu","year":"2020"},{"key":"10.1053\/j.semdp.2021.06.007_bib0102","series-title":"Sarcoma With BCOR Genetic alterations. In: The WHO Classification of Tumours Editorial board. WHO Classification of tumours. Soft tissue and Bone tumours, 5th ed.","first-page":"333","author":"Antonescu","year":"2020"},{"key":"10.1053\/j.semdp.2021.06.007_bib0103","series-title":"Tumors of the Peripheral Nervous system. AFIP Atlas of Tumor pathology, Fascicle 19, 4th Series","first-page":"211","article-title":"Neurofibroma","author":"Antonescu","year":"2013"},{"key":"10.1053\/j.semdp.2021.06.007_bib0104","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s40291-013-0019-6","article-title":"New insights into the genetics of neuroblastoma","volume":"17","author":"Sridhar","year":"2013","journal-title":"Mol Diagn Ther"},{"key":"10.1053\/j.semdp.2021.06.007_bib0105","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/pbc.24433","article-title":"Children's oncology group's 2013 blueprint for research: neuroblastoma","volume":"60","author":"Park","year":"2013","journal-title":"Pediatr Blood Canc"},{"key":"10.1053\/j.semdp.2021.06.007_bib0106","first-page":"1","article-title":"Statistical framework in support of a revised children's oncology group neuroblastoma risk classification system","volume":"2","author":"Naranjo","year":"2018","journal-title":"JCO Clin Canc Inform"},{"key":"10.1053\/j.semdp.2021.06.007_bib0107","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1200\/JCO.2008.16.6785","article-title":"The international neuroblastoma risk group (inrg) classification system: an inrg task force report","volume":"27","author":"Cohn","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2021.06.007_bib0108","article-title":"International neuroblastoma pathology committee. subgrouping of unfavorable histology neuroblastomas with immunohistochemistry toward precision prognosis and therapy stratification","volume":"3","author":"Ikegaki","year":"2019","journal-title":"JCO Precis Oncol"},{"key":"10.1053\/j.semdp.2021.06.007_bib0109","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1200\/JCO.1993.11.8.1466","article-title":"Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment","volume":"11","author":"Brodeur","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2021.06.007_bib0110","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/pbc.21684","article-title":"Lung metastases in neuroblastoma at initial diagnosis: a report from the international neuroblastoma risk group (inrg) project","volume":"51","author":"Dubois","year":"2008","journal-title":"Pediatr Blood Canc"},{"key":"10.1053\/j.semdp.2021.06.007_bib0111","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1470-2045(13)70548-5","article-title":"Childhood cancer survival in europe 1999\u20132007: results of eurocare-5\u2014a population-based study","volume":"15","author":"Gatta","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.semdp.2021.06.007_bib0112","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1200\/JCO.2011.35.9570","article-title":"Prognostic value of the stage 4s metastatic pattern and tumor biology in patients with metastatic neuroblastoma diagnosed between birth and 18 months of age","volume":"29","author":"Taggart","year":"2011","journal-title":"J Clin Oncol"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257021000460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257021000460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:22:20Z","timestamp":1760037740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257021000460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":112,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0740257021000460"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2021.06.007","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mediastinal neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: Pathology review and diagnostic approach","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semdp.2021.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}